Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement
Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement
Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement
Submitted by
admin
on June 14, 2014 - 9:51am
Source:
Pipeline Review
News Tags:
Takeda
Affymax
Omontys
anemia
Headline:
Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement
Do Not Allow Advertisers to Use My Personal information
